Coverage dated October 2, 2023 to October 3, 2023

Novavax's new COVID vaccine cleared for use by FDA

Headline from Live Science

An updated COVID-19 vaccine made by Novavax has been authorized by the FDA, joining the two vaccines already cleared for use.

Live Science's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

20 articles, oldest first.

Green Field Reporter
US adds another option for fall COVID vaccination with updated Novavax shots - The Daily Reporter (opens Green Field Reporter)
Published Oct 2, 2023
Green Field Reporter's feed description
WASHINGTON (AP) — U.S. regulators on Tuesday authorized another option for fall COVID-19 vaccination, updated shots made by Novavax. Updated vaccines from Pfizer and Moderna began rolling out last month, intended for adults and children as young as age 6 months.
WHEC Rochester
US adds another option for fall COVID vaccination with updated Novavax shots (opens WHEC Rochester)
Published Oct 2, 2023
WHEC Rochester's feed description
WASHINGTON (AP) — U.S. regulators on Tuesday authorized another option for fall COVID-19 vaccination, updated shots made by Novavax.
Forbes
FDA Approves Novavax’s New Covid Vaccine Designed To Protect Against The Latest Strain (opens Forbes)
Published Oct 2, 2023
Forbes's feed description
At the recommendation of the FDA, the new boosters protect against XBB variants, which made up 95% of all U.S. Covid cases in June.
Local News 8
FDA signs off on updated protein-based Covid-19 vaccine from Novavax (opens Local News 8)
Published Oct 2, 2023
Local News 8's feed description
The US Food and Drug Administration on Tuesday authorized Novavax’s updated protein-based Covid-19 vaccine for people 12 and older.
Seattle Times
Another fall COVID option in U.S.: updated Novavax shot (opens Seattle Times)
Published Oct 2, 2023
Seattle Times's feed description
U.S. regulators have added another option for fall COVID-19 vaccination: updated shots made by Novavax.
Wall Street Journal
FDA Authorizes Novavax’s Updated Covid Vaccine (opens Wall Street Journal)
Published Oct 2, 2023
Wall Street Journal's feed description
The shot has been updated to target a strain of the coronavirus that was circulating earlier this year.
CBS News
FDA authorizes Novavax's updated COVID vaccine for fall 2023 (opens CBS News)
Published Oct 2, 2023
CBS News's feed description
Many previously vaccinated Americans will be eligible to get Novavax for the first time.
Live Science
Novavax's new COVID vaccine cleared for use by FDA (opens Live Science)
Published Oct 3, 2023
Live Science's feed description
An updated COVID-19 vaccine made by Novavax has been authorized by the FDA, joining the two vaccines already cleared for use.
WTOP Washington DC
Updated Novavax COVID-19 vaccine wins FDA approval (opens WTOP Washington DC)
Published Oct 3, 2023
WTOP Washington DC's feed description
The Food and Drug Administration has granted emergency use approval for Gaithersburg, Maryland-based Novavax’s updated COVID-19 booster shot.
NBC 5 Dallas-Fort Worth
Novavax updated Covid vaccine wins FDA, CDC backing, paving way to reach Americans within days (opens NBC 5 Dallas-Fort Worth)
Published Oct 3, 2023
NBC 5 Dallas-Fort Worth's feed description
Health officials see Novavax’s protein-based vaccine as a valuable alternative for people who don’t want to take messenger RNA shots from Pfizer and Moderna.
MedicalXpress
FDA approves updated Novavax COVID vaccine (opens MedicalXpress)
Published Oct 3, 2023
MedicalXpress's feed description
Federal regulators on Tuesday gave the go-ahead to an updated Novavax COVID vaccine, giving Americans a more traditional alternative to two recently revamped mRNA vaccines.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.